(TSX:OM),(Boerse Frankfurt – Freiverkehr:0B51),(OTC US:OMZNF),(Other OTC:OMZNF),(TSX-V:OM), TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company” or “Osisko Metals“) (TSX: OM; OTCQX: OMZNF; FRANKFURT: OB51) is pleased to announce that it will be uplisting to the Toronto Stock Exchange (the “TSX“) effective at market open on Friday, August 22, 2025. The common shares […]
(NASDAQ:TWIN), MILWAUKEE, Aug. 20, 2025 (GLOBE NEWSWIRE) — Twin Disc, Inc. (NASDAQ: TWIN), today announced that Chief Executive Officer John Batten and Chief Financial Officer Jeff Knutson are presenting at the Three Part Advisors Midwest IDEAS Conference in Chicago on Wednesday, August 27 at 7:55 am Central. In conjunction with the event, Twin Disc executives
LOUISVILLE, K.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Boehringer Ingelheim for Hernexeos(R) (Zongertinib). The Food and Drug Administration approved Hernexeos for the treatment of adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2
(NASDAQ:OLMA), SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences: Citi's 2025 Biopharma Back to
(NASDAQ:IRTC), SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences. Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025,
(NASDAQ:BIOA), EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences: Citi's 2025 Biopharma Back to School Conference
MDWerks' Two Trees Beverage Subsidiary Announces Debut of Crusher Claw, a Private Label Flavored Whiskey Produced for Pinchy's Restaurant Group, LLC GlobeNewswire August 20, 2025 GREEN COVE SPRINGS, Fla., Aug. 20, 2025 (GLOBE NEWSWIRE) — MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology,
Twin Disc to Present at Midwest IDEAS Conference GlobeNewswire August 20, 2025 MILWAUKEE, Aug. 20, 2025 (GLOBE NEWSWIRE) — Twin Disc, Inc. (NASDAQ: TWIN), today announced that Chief Executive Officer John Batten and Chief Financial Officer Jeff Knutson are presenting at the Three Part Advisors Midwest IDEAS Conference in Chicago on Wednesday, August 27 at
iRhythm Technologies to Participate in Upcoming Investor Conferences GlobeNewswire August 20, 2025 SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor
BioAge Labs to Present at Upcoming Investor Conferences GlobeNewswire August 20, 2025 EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the